Issue 31, 2023

Opportunities and challenges in targeting orphan nuclear receptors

Abstract

Nuclear receptor modulation enables pharmacological control of gene expression thus rendering the 48 human nuclear receptors as attractive targets for drug discovery. Several nuclear receptor ligands like glucocorticoids are approved and highly important drugs illustrating the therapeutic potential of nuclear receptor modulation. However, a significant portion of the nuclear receptor family is still poorly explored for new therapeutic opportunities which is due to a lack of potent, selective and well-characterized ligands. Preliminary evidence supports great therapeutic potential of several orphan nuclear receptors in various pathologies underlining the need for high-quality chemical tools to enable target validation. Here, we evaluate the characteristics of available nuclear receptor modulators and the gaps in coverage of the nuclear receptor family with chemical tools. We review successful approaches to nuclear receptor modulator development and highlight the opportunities and challenges in closing the gaps of missing tools for understudied nuclear receptors to open new therapeutic avenues.

Graphical abstract: Opportunities and challenges in targeting orphan nuclear receptors

Article information

Article type
Feature Article
Submitted
27 ফেব্রু. 2023
Accepted
24 মার্চ 2023
First published
31 মার্চ 2023

Chem. Commun., 2023,59, 4551-4561

Opportunities and challenges in targeting orphan nuclear receptors

L. Isigkeit and D. Merk, Chem. Commun., 2023, 59, 4551 DOI: 10.1039/D3CC00954H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements